PharmaCielo Ltd. (TSXV:PCLO)

Market Cap	13.16M -44.6%
Revenue (ttm)	2.27M -12.5%
Net Income	-6.56M
EPS	-0.04
Shares Out	187.98M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	773,563
Average Volume	51,409
Open	0.0800
Previous Close	0.0800
Day's Range	0.0700 - 0.0800
52-Week Range	0.0250 - 0.1650
Beta	0.47
RSI	48.26
Earnings Date	Mar 19, 2026

About PharmaCielo

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Marc Lustig
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: PCLO

Financial Performance

In fiscal year 2025, PharmaCielo's revenue was 3.17 million, a decrease of -8.81% compared to the previous year's 3.48 million. Losses were -9.10 million, -0.50% less than in 2024.